Harvest One Cannabis Inc. reports unaudited financial highlights for year ended June 30th, 2017
VANCOUVER, British Columbia, Aug. 31, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company”) reports unaudited highlights of the Company’s anticipated fiscal 2017 financial results for the year ended June 30th, 2017. The Company’s full audited financial statements and related management discussion and analysis are expected to be filed on SEDAR before September 30, 2017.
As previously announced on April 27th, 2017 Harvest One acquired 100% of the issued and outstanding shares (the “Transaction”) of United Greeneries Holdings Ltd. (“United Greeneries”) and Satipharm AG (“Satipharm”) from PhytoTechMedical (UK) Pty Ltd., a wholly owned subsidiary of MMJ PhytoTech Limited (“MMJ”). As a result of the Transaction, MMJ holds approximately 60% of the issued and outstanding shares of Harvest One. More information about the Transaction can be obtained from the Company’s Filing Statement filed on SEDAR at www.sedar.com and in the Company’s June 30, 2017 consolidated financial statements when filed.
About Harvest One
Harvest One controls operations across the entire cannabis value chain through three business units, with Harvest One serving as the umbrella company over horticultural arm United Greeneries and medical arm Satipharm AG. Each business is strategically located in favorable jurisdictions with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation license, making Harvest One one of only a few companies globally with the capacity to commercially cultivate cannabis in a federally regulated environment.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.